Comparison of Parent and Teacher Reports of Attention-Deficit/Hyperactivity Disorder Symptoms from Two Placebo-Controlled Studies of Atomoxetine in Children

Biological Psychiatry

Volumn 60, Issue 10, 2006, Pages 1106-1110

  Biederman, Joseph ^c   Gao, Haitao ^b   Rogers, Ann K ^b   Spencer, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c NONE

Author keywords

Atomoxetine; attention deficit hyperactivity disorder; clinical trials; long acting treatments; parent reports; pooled analysis

Indexed keywords

ATOMOXETINE; PLACEBO;

ADOLESCENT; ANALYSIS OF COVARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE CALCULATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; SYMPTOM; THERAPY EFFECT;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARENTS; PERSONALITY ASSESSMENT; PROPYLAMINES; TEACHING; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750442914     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.036     Document Type: Article

References (21)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed (2000), American Psychiatric Association, Washington, DC text revision
2. Barkley R.A., Murphy K.R., and Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 98 (1996) 1089-1095
3. Biederman J., Faraone S., Monuteaux M.C., and Grossbard J.R. How informative are parent reports of attention-deficit/hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics 113 (2004) 1667-1671
4. Conners C.K. Conners' rating scales: revised technical manual (1997), Multi-Health Systems Inc, North Towanda, NY
5. DuPaul G.J., Power T.J., Anastopoulos A.D., and Reid R. ADHD Rating Scale-IV: checklists, norms, and clinical interpretations (1998), The Guilford Press, New York
6. Faraone S.V., Biederman J., and Roe C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol 22 (2002) 468-473
7. Faries D.E., Yalcin I., Harder D., and Heiligenstein J.H. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Attention Disorders 5 (2001) 107-115
8. Gabbard G.O. Treatments of Psychiatric Disorders. 3rd ed (2001), American Psychiatric Association, Washington, DC
9. Greene R.W., Biederman J., Faraone S.V., Monuteaux M.C., Mick E., DuPre E.P., et al. Social impairment in girls with ADHD: patterns, gender comparisons, and correlates. J Am Acad Child Adolesc Psychiatry 40 (2001) 704-710
10. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (1997) 980-988
11. Mannuzza S., Klein R.G., Konig P.H., and Giampino T.L. Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiatry 46 (1989) 1073-1079
12. Mash E., and Barkley R.A. Treatment of childhood disorders. 2nd ed (1998), Guilford Publications, New York
13. Michelson D., Allen A.J., Busner J., Casat C., Dunn D., Kratochvil C., et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159 (2002) 1896-1901
14. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1073-1086
15. Rutter M. Syndromes attributed to "minimal brain dysfunction" in childhood. Am J Psychiatry 139 (1982) 21-33
16. Rutter M., Tuma A.H., and Lann I. Assessment and diagnosis in child psychopathology (1988), Guilford Press, New York
17. Schachter H.M., Pham B., King J., Langford S., and Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165 (2001) 1475-1488
18. Talbott J.A., Hales R.E., and Yudofsky S.C. Textbook of Psychiatry (1988), American Psychiatric Press, Washington, DC
19. Weiss M., Tannock R., Kratochvil C., Dunn D., Velez-Borras J., Thomason C., et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44 (2005) 647-655
20. Wiener J.M. Textbook of child & adolescent psychiatry (1991), American Psychiatric Press, Washington, DC
21. World Medical Association (2000). Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects. Adopted by the 18th World Medical Association General Assembly, Helsinki, Finland, June 1964; and amended by the 52nd WMA General Assembly, Edinburgh, Scotland (2000) October